Effects of Custom 3D Printed Insoles and Short Foot Exercises in Pes Planus

November 4, 2026 updated by: Emrah Afsar, Kutahya Health Sciences University

The Effect of Custom 3D Printed Insoles and Short Foot Exercises on Foot Posture, Balance, and Gait Parameters in Individuals With Pes Planus

The primary purpose of this study is to evaluate the effects of combining custom 3D-printed medial arch-supported insoles with short foot exercises on foot posture, balance, and gait parameters in individuals with pes planus (flat feet). Furthermore, the study will investigate the impact of this combined intervention on secondary outcomes, including pain levels, health-related quality of life, and functional exercise capacity measured by the 6-Minute Walk Test.

Study Overview

Status

Recruiting

Conditions

Detailed Description

Participants will be recruited through personal networks and social media platforms using a snowball sampling method. Potential candidates will be screened for pes planus in accordance with established literature protocols, utilizing the Foot Posture Index-6 (FPI-6) and the Navicular Drop Test.

Eligible individuals who meet the criteria for pes planus will undergo 3D foot scanning. Based on the obtained data, customized medial arch-supported insoles will be manufactured using 3D printing technology. Participants will be instructed to use these custom insoles in their daily lives for a total of 8 weeks. Concurrently, they will be assigned a daily short foot exercise (intrinsic muscle training) program. Each exercise repetition will involve a 5-second hold, and the entire protocol will be maintained for 8 weeks.

All clinical, functional, and biomechanical evaluations-including foot posture, dynamic balance, comprehensive gait and plantar pressure analysis (via the Zebris system), pain intensity, quality of life, and functional walking capacity-will be conducted at two time points: at baseline and at the end of the 8-week intervention period.

For statistical analysis, depending on the normality of data distribution, either a paired t-test or a Wilcoxon signed-rank test will be used to evaluate within-group changes between baseline and week 8. To determine the magnitude of the intervention effect, Cohen's d effect sizes for dependent measures will be calculated and reported alongside 95% confidence intervals.

Study Type

Interventional

Enrollment (Estimated)

54

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Kütahya, Turkey (Türkiye)
        • Recruiting
        • Kutahya Health Science University
        • Contact:
        • Principal Investigator:
          • Emrah Afsar, Phd
        • Sub-Investigator:
          • Zeynep Sena Namaz, MSc

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 35 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Aged between 18 and 35 years.
  • Presence of pes planus, defined as a Navicular Drop test value > 10 mm and a Foot Posture Index-6 (FPI-6) score between +6 and +12.
  • Willingness to volunteer for the study and provide written informed consent.

Exclusion Criteria:

  • Presence of rigid pes planus.
  • Hallux valgus.
  • Hallux rigidus.
  • Calcaneal spur (heel spur).
  • History of any neurological, cardiovascular, or systemic diseases.
  • History of any orthopedic disease affecting the lower extremities.
  • History of lower extremity surgery.
  • Body Mass Index (BMI) ≥ 30 kg/m².

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Insole and Exercise Group

All participants in this group will receive custom 3D printed insoles and perform a short foot exercise program.

The intervention consists of a combined biomechanical and active rehabilitation approach for individuals with pes planus:

  1. Custom 3D Printed Insoles: The participants' feet will be 3D scanned, and custom insoles will be manufactured using 3D printing technology. Participants will be recommended to use these personalized insoles during their daily activities for a total of 8 weeks.
  2. Short Foot Exercises (SFE): Participants will perform a short foot exercise (foot core / intrinsic muscle) program aimed at increasing intrinsic foot muscle activation. The exercise protocol will be performed daily for 8 weeks, with each repetition held for five seconds.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Foot Posture Index-6 (FPI-6)
Time Frame: Baseline and 8 Weeks

Assesses foot posture across 6 criteria. Total scores range from -12 (highly supinated) to +12 (highly pronated).

Baseline and 8 Weeks
Navicular Drop Test (NDT)
Time Frame: Baseline and 8 Weeks

Assesses medial longitudinal arch height difference (in mm) between seated (non-weight bearing) and standing (weight bearing) positions. Higher values indicate increased pronation.

Baseline and 8 Weeks
Modified Star Excursion Balance Test (MSEBT)
Time Frame: Baseline and 8 Weeks

Evaluates dynamic balance by measuring the maximum reach distance (in cm) in three directions: anterior, posteromedial, and posterolateral.

Baseline and 8 Weeks
Spatiotemporal Gait and Plantar Pressure Parameters
Time Frame: Baseline and 8 Weeks

Evaluated using the Zebris system. Includes gait speed (m/s), cadence (steps/min), stride length (cm), stance percentage (%), and plantar pressure parameters (e.g., peak pressure, contact area).

Baseline and 8 Weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Numeric Pain Rating Scale (NPRS)
Time Frame: Baseline and 8 Weeks

Assesses pain intensity on an 11-point scale ranging from 0 (no pain) to 10 (worst imaginable pain).

Baseline and 8 Weeks
36-Item Short Form Health Survey (SF-36)
Time Frame: Baseline and 8 Weeks

Assesses health-related quality of life across 8 domains. Subscale scores are transformed to a 0 to 100 scale, where higher scores indicate better health status.

Baseline and 8 Weeks
6-Minute Walk Test (6MWT) and Modified Borg Scale
Time Frame: Baseline and 8 Weeks

Evaluates functional capacity by measuring the total distance walked in 6 minutes (in meters). Perceived exertion is assessed before and after the test using the Modified Borg Scale (0-10 scale; higher scores indicate greater exertion).

Baseline and 8 Weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Emrah Afsar, Phd, Kutahya Health Science University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 26, 2026

Primary Completion (Estimated)

October 26, 2027

Study Completion (Estimated)

December 26, 2027

Study Registration Dates

First Submitted

October 19, 2026

First Submitted That Met QC Criteria

October 19, 2026

First Posted (Actual)

October 26, 2026

Study Record Updates

Last Update Posted (Actual)

November 5, 2026

Last Update Submitted That Met QC Criteria

November 4, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 3D Insole in Pes Planus
  • TDK-2026-365 (Other Grant/Funding Number: Kutahya Health Sciences University Scientific Research Projects Unit)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe